Cutting Edge Glaucoma - Issue 2

Abstract In the management of glaucoma, recent and upcoming innovations have the potential to con- tribute to both the efficacy of intraocular pressure (IOP) monitoring and the number of available treatment options. These new devices and procedures have two things in common: they are part of the trend in medicine towards miniaturization, and they require a limited surgical procedure to become effective. This review focuses on the Eyemate (Argos) intraocular sensor, which offers a new way to reliably measure 24 h IOP, and on intraocular sustained release systems for phar- macological glaucoma therapy. It also briefly reflects on the miniature implants currently used in minimally invasive glaucoma surgery (MIGS). Keywords: Adherence, CyPass microstent; Eyemate (Argos) sensor, Glaucoma, Hydrus micros- tent, Intraocular drug delivery systems, Intraocular pressure (IOP), iStent inject, Minimally inva- sive glaucoma surgery (MIGS), XEN gel Introduction Glaucoma is considered the second most frequent cause of global blindness. The most common form of the disease, primary open-angle glaucoma (POAG), afflicts nearly 75% of the projected 80 million glaucoma patients worldwide [37]. Miniaturization in Glaucoma Monitoring and Treatment: A Review of New Technologies that Require a Minimal Surgical Approach H. Burkhard Dick, TimSchultz, Ronald D. Gerste H. B. Dick, T. Schultz, R. D. Gerste (  ) University Eye Clinic, Ruhr University, Bochum, Germany e-mail: rdgerste@aol.com